Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: richard davis who wrote (3442)	1/14/1998 9:48:00 PM
From: Hank	Read Replies (1) \| Respond to of 4342

Rick, It's simple. PRLN fits into Biomar's plans because Biomar is marketing a screening technology that detects the genetic elements that predispose a person to diseases like cancer. A perfect symbiotic relationship. Biomar tells you if you're at risk and if you are, PRLN provides the herbal preventative therapy. Now lets see if they can pull it off. I'm not buying back in just yet. They have a long way to go before I'm convinced they are worth risking more money on. However, I'm impressed that Biomar was able to pull it off. Congratulations to Biomar and Colin Campbell for pulling PRLN out of the fire! Let's not forget that without Campbell PRLN had no chance since Campbell was PRLN's only reliable connection to China- the source for it's herbs. Hank

To: richard davis who wrote (3442)	1/14/1998 10:38:00 PM
From: Richard Mazzarella	Read Replies (1) \| Respond to of 4342

Richard, hello. This looks like Biomar will be using PRLN as a public company shell for its activities. Did anyone notice the Cornell connection? The fruit doesn't fall far from the tree. <VBG> I think that Biomar will attempt to restore PRLN technology. I wonder if this provides an opening for Babish to return in style? The funding gives new life to this outfit. Pick up some shares while they are still cheap. The market may perceive this as the IPO you suggest. Little near term downside and a large potential upside IMO.